Since our previous study revealed that enhanced AKT activation parallels progressive tumor stage and increased resistance of MET1 and MET4 cells to therapeutic drugs [24], we investigated the impact of LUT treatment on the phosphorylation and thus activation of AKT (Ser473) using western blot analysis (Figure 2A). This evidence concerns the gene AKT1 and neoplasm.